New Study Warns That Trump's Drug Price Controls Could Harm U.S. Innovation and Access A recent brief from the Pacific Research Institute cautions that Trump’s drug pricing policies could undermine the U.S. pharmaceutical innovation and access to essential medications.

New Study Warns That Trump's Drug Price Controls Could Harm U.S. Innovation and Access #USA #Sacramento #Trump #Pacific_Research_Institute #Drug_Price_Controls